AccentCare Inc., entered into a definitive agreement to be purchased by Advent International from Oak Hill Capital Partners on May 16, 2019.
AccentCare is the sixth largest home health platform and the third largest personal care platform in the United States, offering a range of services – from personal, non-medical care to skilled nursing, rehabilitation, hospice care and care management – across 16 states. The company serves health systems, physician practices and managed care organizations, and includes strategic joint ventures and partnerships.
Benesch served as health care regulatory counsel to AccentCare in connection with the transaction. The Benesch team included Alan Schabes and Laura Pone.
Latest News
Benesch Partner Tara Raghavan Named to 2026 Lawdragon 500 Leading Global IP Lawyers List
Benesch is pleased to announce that Partner Tara Raghavan has been named to the 2026 Lawdragon 500 Leading Global IP …
Benesch Energy Lead Trevor Alexander Named to 2026 Lawdragon 500 Global Leaders in Energy List
Benesch is pleased to announce that Trevor Alexander, lead of Benesch’s Energy Practice Group, has been named to the 2026 …
Benesch Partner Juan Morado Jr. Named 2026 “Notable Leader in Law” by Crain’s Chicago Business
Benesch is pleased to announce that Juan Morado Jr., a partner in the firm’s Healthcare Practice Group, has been selected …
Michael Chu Joins Benesch’s Intellectual Property Practice Group from McDermott Will & Schulte, Strengthening Patent Litigation Bench
Benesch is pleased to announce that Michael Chu has joined the firm as a partner in its growing Intellectual Property Practice Group in Chicago. His arrival marks the latest milestone in the continued expansion and success of a thriving practice that is building momentum across industries and technologies. Michael brings more than three decades of experience representing clients in complex patent and intellectual property disputes, as well as advising domestic and international companies on patent prosecution, intellectual property portfolio strategy, licensing, post-grant proceedings, trade and cross-border intellectual property matters.